Evaluation of Kinesophobia in Patients With Metabolic Syndrome
1 other identifier
observational
96
1 country
1
Brief Summary
Metabolic syndrome (MS) is a public health problem characterized by central obesity, increased blood pressure and triglyceride levels, decreased blood HDL levels and the presence of insulin resistance (1).Kinesiophobia is a fear of irrational movement that develops because of its belief in susceptibility to injury and is associated with low levels of physical activity. Considering that exercise improves metabolic processes in people with MS, we aimed to evaluate the presence of kinesophobia in patients with MS. Patients aged 45-65 years diagnosed with metabolic syndrome and healthy controls will be included in the study. Patients with rheumatic and neurological diseases,history of trauma, gonarthrosis, lumbar disc hernia, previous fractures, fibromyalgia and those who have experienced pain for the last week will be excluded. The participants will be filled in the Short Form-36 (SF-36), the Hospital Anxiety and Depression Scale, and the Tampa Kinesiophobia Scale. 48 patients with MS and 48 healthy participants will be included in the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 25, 2019
CompletedFirst Submitted
Initial submission to the registry
October 9, 2019
CompletedFirst Posted
Study publicly available on registry
October 10, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2020
CompletedJanuary 10, 2020
January 1, 2020
4 months
October 9, 2019
January 8, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Tampa Kinesiophobia Scale
People takes between 17-68 total a score. The score of the person shows high kinesiophobia on the scale
3 months
Study Arms (2)
Patients with metabolic syndrome
Healthy controls
Interventions
The presence of kinesiofobia in patients with metabolic syndrome
Eligibility Criteria
45-65 years old men and female with metabolic syndrome and healthy controls
You may qualify if:
- Patients with metabolic syndrome
You may not qualify if:
- Patients with rheumatic disease
- Patients with neurologic disease
- Patients with history of trauma
- Patients with gonartrosis
- Pateints with fibromialgia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dilek Eker Büyükşireci
Çorum, Central Anatolia, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Specialist doctor
Study Record Dates
First Submitted
October 9, 2019
First Posted
October 10, 2019
Study Start
September 25, 2019
Primary Completion
February 1, 2020
Study Completion
February 1, 2020
Last Updated
January 10, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share